Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2IT5
|
||||
| Drug Name |
(2-(4-(trifluoromethoxy)benzyl)phenyl)-N,N-dimethylmethanamine
|
||||
| Synonyms |
CHEMBL492815
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C17H18F3NO
|
||||
| Canonical SMILES |
CN(C)Cc1ccccc1Cc2ccc(OC(F)(F)F)cc2
|
||||
| InChI |
InChI=1S/C17H18F3NO/c1-21(2)12-15-6-4-3-5-14(15)11-13-7-9-16(10-8-13)22-17(18,19)20/h3-10H,11-12H2,1-2H3
|
||||
| InChIKey |
KEIRXXIACQJSMU-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.